Suman S, Parghane RV, Joshi A, Prabhash K, et al. Combined (177) Lu-PSMA-617 PRLT and abiraterone acetate versus (177) Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability. Prostate 2021 Sep 1. doi: 10.1002/pros.24219.
PMID: 34469602